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Supporting Figure 1. A. Representative traces of voltage-clamp current for a wild type recovery experiment 
at Trp154 of the A3B2 receptor. Bars show application of varenicline at concentrations noted. B. Fit of data 
for several suppression experiments to the Hill equation for A3B2. Error bars indicate SEM; n = 5-8. 
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Supporting Figure 2. Fluorination plots for the agonists studied at both stoichiometries of the α4β2 
receptor. Data for nicotine and ACh at A2B3 were previously published by (Xiu et al., 2009) and are 
reproduced here for comparison purposes. Nic = nicotine; Cy = cytisine; Var = varenicline. 
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Supporting Table 1.  EC50 values (nM), fold shift values, Hill coefficients (nH) and current size at +70mV 
(normalized to current size at -110mV). As described previously (Xiu et al., 2009), we interpret an Inorm value 
below 0.10 as corresponding to an essentially pure population of A2B3 receptors and values at or above 
0.20 as corresponding to an essentially pure population of A3B2 receptors. Hill coefficients are generally in 
the typical range, although some heavily fluorinated derivatives shower lower than usual values.  We have 
seen this trend in other studies, but we do not have a structural interpretation. All receptor studies 
reported herein contain a L9’A mutation in the α subunit. Errors are SEM. 
A2B3 Receptor 
Agonist Mutation EC50 (nM) Fold Shift nH Inorm (+70mV) 
 Cy  
Wild type 6.9 ± 0.3 - 1.4 ± 0.1 0.05 ± 0.01 
α4W154 Trp 11 ± 1 1.6 1.1 ± 0.1 0.03 ± 0.01 
α4W154 F-Trp 22 ± 1 3.2 1.1 ± 0.1 0.05 ± 0.01 
α4W154 F2-Trp 21 ± 1 3.0 1.1 ± 0.1 0.08 ± 0.01 
α4W154 F3-Trp 180 ± 10 26 1.3 ± 0.1 0.05 ± 0.03 
α4W154 F4-Trp 210 ± 60 31 0.62 ± 0.08 0.04 ± 0.01 
Var 
Wild type 2.9 ± 0.1 - 1.4 ± 0.1 0.037 ± 0.007 
α4W154 Trp 2.4 ± 0.2 0.8 1.2 ± 0.1 0.043 ± 0.005 
α4W154 F-Trp 5.7 ± 0.2 2.0 1.2 ± 0.1 0.040 ± 0.007 
α4W154 F2-Trp 9.0 ± 0.4 3.1 1.2 ± 0.1 0.05 ± 0.011 
α4W154 F3-Trp 27 ± 1 9.5 1.3 ± 0.1 0.044 ± 0.009 
α4W154 F4-Trp 56 ± 5 20 1.1 ± 0.1 0.033 ± 0.008 
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 Supporting Table 1, continued                     
A3B2 Receptor 
Agonist Mutation EC50 (nM) Fold Shift nH Inorm (+70mV) 
ACh 
Wild type 23 ± 1 - 1.3 ± 0.1 0.30 ± 0.04 
α4W154 Trp 24 ± 1 1.0 1.6 ± 0.1 0.27 ± 0.01 
α4W154 F-Trp 260 ± 10 11 1.2 ± 0.1 0.19 ± 0.01 
α4W154 F2-Trp 290 ± 10 13 1.5 ± 0.1 0.26 ± 0.06 
α4W154 F3-Trp 8200 ± 100 360 0.63 ± 0.03 0.19 ± 0.01 
α4W154 F4-Trp 12000 ± 2000 540 0.63 ± 0.04 0.23 ± 0.02 
Nic 
Wild type 10 ± 1 - 1.7 ± 0.2 0.30 ± 0.04 
α4W154 Trp 8.0 ± 1.0 0.80 1.5 ± 0.3 0.27 ± 0.01 
α4W154 F-Trp 49 ± 2 4.9 1.5 ± 0.1 0.19 ± 0.01 
α4W154 F2-Trp 110 ± 10 11 1.5 ± 0.2 0.26 ± 0.06 
α4W154 F3-Trp 510 ± 60 51 1.1 ± 0.1 0.19 ± 0.01 
α4W154 F4-Trp 1300 ± 100 130 1.1 ± 0.1 0.23 ± 0.02 
Cy 
Wild type 3.9 ± 0.1 - 2.0 ± 0.1 0.24 ± 0.03 
α4W154 Trp 3.8 ± 0.1 1.0 2.1 ± 0.1 0.17 ± 0.02 
α4W154 F-Trp 15 ± 1 3.9 1.3 ± 0.1 0.19 ± 0.02 
α4W154 F2-Trp 35 ± 2 9.0 1.1 ± 0.1 0.19 ± 0.02 
α4W154 F3-Trp 78 ± 5 20 0.95 ± 0.04 0.20 ± 0.02 
α4W154 F4-Trp 120 ± 10 30 0.88 ± 0.05 0.18 ± 0.02 
Var 
Wild type 0.95 ± 0.02 - 1.7 ± 0.1 0.22 ± 0.03 
α4W154 Trp 0.73 ± 0.02 0.77 1.4 ± 0.1 0.30 ± 0.03 
α4W154 F-Trp 2.0 ± 0.2 2.1 1.1 ± 0.1 0.24 ± 0.01 
α4W154 F2-Trp 2.4 ± 0.1 2.5 1.2 ± 0.1 0.21 ± 0.01 
α4W154 F3-Trp 11 ± 1 12 1.0 ± 0.1 0.20 ± 0.02 





Supporting Table 2.  EC50 values (nM), fold shift values, Hill coefficients (nH) and current size at +70mV 
(normalized to current size at -110mV). As described previously (Xiu et al., 2009), we interpret an Inorm value 
below 0.10 as corresponding to an essentially pure population of A2B3 receptors and values at or above 
0.20 as corresponding to an essentially pure population of A3B2 receptors. All receptor studies reported 
herein contain a L9’A mutation in the α subunit. a. Previously reported (Xiu et al., 2009). b. Previously 
reported (Blum et al., 2010). Errors are SEM. 
A2B3 Receptor 
Agonist Mutation EC50 (nM) Fold Shift nH Inorm (+70mV) 
ACh 
α4T155 Thra 410 ± 20 - 1.4 ± 0.1 0.044 ± 0.007 
α4T155 Taha 370 ± 20 0.90 1.3 ± 0.1 0.02 ± 0.01 
β2L119 Leub 440 ± 20 - 1.3 ± 0.1 0.04 ± 0.01 
β2L119 Lahb 3000 ± 100 6.8 1.2 ± 0.1 0.04 ± 0.01 
Nic 
α4T155 Thra 90 ± 10 - 1.6 ± 0.1 0.044 ± 0.007 
α4T155 Taha 1700 ± 100 19 1.2 ± 0.2 0.02 ± 0.01 
β2L119 Leub 120 ± 10 - 1.5 ± 0.1 0.05 ± 0.01 
β2L119 Lahb 800 ± 30 6.7 1.3 ± 0.1 0.06 ± 0.01 
Cy 
α4T155 Thr 15 ± 1 - 1.2 ± 0.1 0.026 ± 0.009 
α4T155 Tah 130 ± 9 8.7 1.2 ± 0.1 0.03 ± 0.01 
β2L119 Leu 8.7 ± 0.5 - 1.2 ± 0.1 0.06 ± 0.02 
β2L119 Lah 540 ± 30 62 1.0 ± 0.1 0.06 ± 0.01 
Var 
α4T155 Thr 2.2 ± 0.1 - 1.3 ± 0.1 0.020 ± 0.002 
α4T155 Tah 30 ± 2 14 1.2 ± 0.1 0.029 ± 0.006 
β2L119 Leu 2.6 ± 0.2 - 1.3 ± 0.1 0.06 ± 0.01 
β2L119 Lah 4.7 ± 0.2 1.8 1.3 ± 0.1 0.05 ± 0.01 
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 Supporting Table 2, continued                 
A3B2 Receptor 
Agonist Mutation EC50 (nM) Fold Shift nH Inorm (+70mV) 
ACh 
α4T155 Thr 20 ± 1 - 1.4 ± 0.1 0.20 ± 0.02 
α4T155 Tah 25 ± 2 1.3 1.2 ± 0.1 0.22 ± 0.01 
β2L119 Leu 26 ± 1 - 1.6 ± 0.1 0.23 ± 0.02 
β2L119 Lah 220 ± 10 8.5 1.2 ± 0.1 0.24 ± 0.03 
Nic 
α4T155 Thr 9.9 ± 0.5 - 1.7 ± 0.1 0.20 ± 0.02 
α4T155 Tah 210 ± 20 21 1.6 ± 0.2 0.22 ± 0.01 
β2L119 Leu 12 ± 1 - 1.6 ± 0.1 0.23 ± 0.02 
β2L119 Lah 67 ± 3 5.6 1.4 ± 0.1 0.20 ± 0.03 
Cy 
α4T155 Thr 3.6 ± 0.4 - 1.4 ± 0.1 0.20 ± 0.04 
α4T155 Tah 96 ± 6 27 1.1 ± 0.1 0.19 ± 0.02 
β2L119 Leu 3.6 ± 0.1 - 1.9 ± 0.1 0.32 ± 0.03 
β2L119 Lah 51 ± 2 14 1.4 ± 0.1 0.24 ± 0.02 
Var 
α4T155 Thr 0.47 ± 0.03 - 1.5 ± 0.1 0.27 ± 0.02 
α4T155 Tah 8.9 ± 0.3 19 1.2 ± 0.1 0.23 ± 0.04 
β2L119 Leu 1.0 ± 0.1 - 1.5 ± 0.1 0.23 ± 0.03 




Supporting Table 3. EC50 values (nM), fold shift values and Hill coefficients (nH) for S-MPP. All receptor 
studies reported herein contain a L9’A mutation in the α subunit. a. Previously reported (Blum et al., 2010). 
Errors are SEM. 
S-MPP 
Receptor Mutation EC50 (nM) Fold Shift nH 
A2B3 
Wild typea 11000 ± 400 - 1.7 ± 0.1 
β2L119 Leua 14000 ± 900 1.3 1.5 ± 0.1 
β2L119 Laha 1100 ± 40 0.08 1.5 ± 0.1 
A3B2 
Wild type  4500 ± 100 - 1.1 ± 0.1 
β2L119 Leu 4200 ± 300 0.93 1.6 ± 0.1 
β2L119 Lah 130 ± 10 0.03 1.2 ± 0.1 
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